← Back
TherapeuticsMD
TXMD · listed on Nasdaq · worth $25.7 million
$1.80
−1.64% on Oct 30
One insider buy in the last year, $14K in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
9.5M shares
82% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought TherapeuticsMD stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Tommy G. Thompson
Bought $14K on Dec 23, 2025 — 8,400 shares at $1.67, 36% of what they now own.
1 of 2 earlier purchases did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of TherapeuticsMD, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company. · updateBaselake Partners6.8%Aug 5
All reports
Every insider trade and SEC report we hold for TherapeuticsMD.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Dec 29, 2025BoughtTommy G. ThompsonDec 29, 2025 · Traded Dec 23, 2025 · Director+36%8,400 @ $1.67$14K